Clinical Textbook of Addictive Disorders

This state-of-the-science reference and text has given thousands of practitioners and students a strong foundation in understanding and treating addictive disorders. Leading experts address the neurobiology of addictions and review best practices in assessment and diagnosis. Specific substances of abuse are examined in detail, with attention to real-world clinical considerations. Issues in working with particular populations--including polysubstance abusers, culturally diverse patients, older adults, chronic pain sufferers, and others--are explored. Chapters summarize the theoretical and empirical underpinnings of widely used psychosocial and pharmacological treatments and clearly describe clinical techniques. New to This Edition *Incorporates a decade's worth of major advances in research and clinical practice. *Updated for DSM-5. *Many new authors; extensively revised with the latest information on specific biological mechanisms, substances, populations, and treatments. *Chapter on motivational interviewing.

I. Foundations of Addiction 1. Neurobiology of Substance Use Disorders: Implications for Treatment, Thomas R. Kosten & Colin N. Haile 2. Historical and Social Context of Psychoactive Substance Disorders, Joseph Westermeyer II. Assessment of Addiction 3. Diagnostic Assessment of Substance Abusers, Deborah Hasin & Bari Kilcoyne 4. Laboratory Testing for Substances of Abuse, D. Andrew Baron & David A. Baron III. Substances of Abuse 5. Alcohol, Ed Nace 6. Nicotine Dependence, David Kalman, Amy Harrington, Joseph DiFranza, Lori Pbert, & Douglas Ziedonis 7. Opioids, Sudie E. Back, Jenna L. McCauley, Kelly S. Barth, & Kathleen T. Brady 8. Cannabis, Alicia R. Murray & Frances R. Levin 9. Hallucinogens and Inhalants, Stephen Ross & Avram H. Mack 10. Caffeine, Laura M. Juliano & Greta Bielacyzc Raglan 11. Stimulants, Richard Rawson, Larissa Mooney, & Walter Ling 12. Cocaine, Evaristo Akerele & Niru Nahar 13. Sedatives/Hypnotics and Benzodiazepines, Robert L. DuPont, William M. Greene, & Caroline M. DuPont IV. Special Populations 14. Polysubstance Use, Abuse, and Dependence, Richard N. Rosenthal, Petros Levounis, & Abigail J. Herron 15. Co-Occurring Substance Use Disorders and Other Psychiatric Disorders, Benjamin C. Silverman, Lisa M. Najavits, Roger D. Weiss 16. Gambling Disorder and Other "Behavioral" Addictions, Liana R. N. Schreiber, Marc N. Potenza, & Jon E. Grant 17. Substance Abuse in Minority Populations, John Franklin 18. Addiction in the Workplace, Laurence Westreich 19. Forensic Approaches to Substances of Abuse, Avram H. Mack 20. Patients with Chronic Pain and Opioid Misuse, Deborah L. Haller & Sidney H. Schnoll 21. Substance Use among Older Adults, Steve Koh, Robert Gorney, Nicolas Badre, & Dilip Jeste 22. HIV/AIDS and Substance Use Disorders, Cheryl Ann Kennedy & Steven J. Schleifer 23. Women and Substance Abuse, Dawn E. Sugarman, Christina Brezing, & Shelly F. Greenfield 24. Substance Use Disorders in Adolescence, Oscar G. Bukstein & Yifrah Kaminer V. Treatments for Addictions 25. Matching and Differential Therapies: Providing Substance Abusers with Appropriate Treatment, Kathleen M. Carroll & Brian D. Kiluk 26. Individual Psychodynamic Psychotherapy, Lance M. Dodes & Edward J. Khantzian 27. Cognitive Therapy, Judith S. Beck, Bruce S. Liese, & Lisa M. Najavits 28. Group Therapy, Self-Help Groups, and Network Therapy, Marc Galanter 29. Family Therapy Approaches, Edward Kaufman 30. Motivational Interviewing, Jennifer L. Smith, Kenneth M. Carpenter, R. Morgan Wain, & Edward V. Nunes 31. Dialectical Behavior Therapy for Individuals with Borderline Personality Disorder and Substance Use Disorders, Dorian Hunter, M. Zachary Rosenthal, Thomas R. Lynch, and Marsha M. Linehan 32. Psychopharmacological Treatments, Larissa J. Mooney & Elinore F. McCance-Katz Index

Avram H. Mack, MD, is Associate Chair for Quality and Safety at the Childrens Hospital of Philadelphia, where he is a practicing psychiatrist with a focus on substance use disorders and forensic, child, adult, and consultationliaison psychiatry. Dr. Mack leads efforts on quality and patient safety and has had extensive experience as a teacher and administrator in undergraduate and graduate medical education for trainees and staff at the University of Pennsylvania, the Childrens Hospital of Philadelphia, and previously at Georgetown University. He is board-certified in general psychiatry, child and adolescent psychiatry, forensic psychiatry, and addiction medicine and presents, publishes, and testifies extensively regarding substance abuse. A past president of the Washington Psychiatric Society, he served on the board of directors of the American Psychiatric Association and on the Impaired Physicians Committee of the Medical Society of the District of Columbia. A distinguished Fellow of the American Psychiatric Association and a Fellow of the American College of Psychiatrists, Dr. Mack is a recipient of the Education Award presented by the Association for Academic Psychiatry in recognition of his efforts in advancing the patient safety movement within psychiatry. Kathleen T. Brady, MD, PhD, is Distinguished University Professor and Associate Provost for Clinical and Translational Science at the Medical University of South Carolina. Her interests include drug and alcohol abuse/addiction and comorbid conditions. A board-certified psychiatrist, Dr. Brady leads numerous research projects and served as president of the American Academy of Addiction Psychiatry, a member of the Scientific Advisory Council of the National Institute on Drug Abuse, and a board member of the College on Problems of Drug Dependence. She has authored over 300 publications; presented at conferences, grand rounds, and symposia; and received numerous awards. Sheldon I. Miller, MD, until his death in 2011, was Emeritus Professor of Psychiatry and former Chairman of the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. Recognized as a national leader in addiction psychiatry, he was a cofounder of the American Academy of Addiction Psychiatry. Dr. Miller was the author of more than 100 publications and Editor-in-Chief of the American Journal on Addictions. He served on the Board of Directors of the Accreditation Council for Graduate Medical Education and the American Board of Emergency Medicine and was a Distinguished Fellow of the American Psychiatric Association and a member of the Group for the Advancement of Psychiatry. Richard J. Frances, MD, is Clinical Professor of Psychiatry at New York University School of Medicine and Adjunct Professor at Rutgers New Jersey Medical School. He maintains a private practice in New York and was instrumental in the recognition of addiction psychiatry as a medical subspecialty. Board-certified in psychiatry and addiction psychiatry, Dr. Frances was a cofounder and first president of the American Academy of Addiction Psychiatry, Director of Education at the University of Medicine and Dentistry of New Jersey (now part of Rutgers Biomedical and Health Sciences), Chair of the Department of Psychiatry at Hackensack University Medical Center, and President and Medical Director of Silver Hill Hospital. He has also held leadership positions at New York HospitalCornell Medical Center and has a special interest in addiction, with a focus on impaired professionals.